Svetlana Cherlin

Svetlana Cherlin

Senior Research Associate (Biostatistician)

Population Health Sciences Institute

Svetlana Cherlin

Contact

Publications

Quickly discover relevant content by filtering publications.
Svetlana Cherlin, Theophile Bigirumurame, Michael J Grayling, Jérémie Nsengimana, Luke Ouma, Aida Santaolalla, Fang Wan, S Faye Williamson, James MS Wason (2023). Utilising high-dimensional data in randomised clinical trials: A review of methods and practice. Research Methods in Medicine & Health Sciences.

Cite DOI URL

Miranda Morton, Nina Wilson, Tara Marie Homer, Laura Simms, Alison Steel, Rebecca Maier, James Wason, Laura Ternent, Alaa Abouhajar, Maria Allen, Richard Joyce, Victoria Hildreth, Rachel Lakey, Svetlana Cherlin, Adam Walker, Graham Devereux, James D Chalmers, Adam T Hill, Charles Haworth, John R Hurst, Anthony De Soyza (2023). Dual bronchodilators in Bronchiectasis study (DIBS): protocol for a pragmatic, multicentre, placebo-controlled, three-arm, double-blinded, randomised controlled trial studying bronchodilators in preventing exacerbations of bronchiectasis. BMJ Open.

Cite DOI URL

Grayling MJ, Bigirumurame T, Cherlin S, Ouma L, Zheng H, Wason J (2021). Innovative trial approaches in immune-mediated inflammatory diseases: Current use and future potential. BMC Rheumatol 2021; 5:21.

DOI

Cherlin S, Wason JMS (2021). Developing a predictive signature for two trial endpoints using the cross-validated risk scores method. Biostatistics 2021; DOI: 10.1093/biostatistics/kxaa055.

Castellucci LC, Almeida L, Cherlin S, Fakiola M, Francis RW, Carvalho EM, Santos da Hora A, do Lago TS, Figueiredo AB, Cavalcanti CM, Alves NS, Morais KLP, Teixeira-Carvalho A, Dutra WO, Gollob KJ, Cordell HJ, Blackwell JM (2021). A genome-wide association study identifies SERPINB10, CRLF3, STX7, LAMP3, IFNG-AS1, and KRT80 as risk loci contributing to cutaneous leishmaniasis in Brazil. Clin Infect Dis 2021; 72:e515-25.

DOI

Vergis N, Phillips R, Cornelius V, Katsarou A, Youngstein T, Cook L, Willicombe M, Pilay C, Shturova T, Almonte M, Charania A, Turner R, Kon OM, Cooke G, Thursz M, Cherlin S, Wason J, Milojkovic D, Innes AJ, Cooper N (2021). Multi-arm Trial of Inflammatory Signal Inhibitors (MATIS) for hospitalised patients with mild or moderate COVID-19 pneumonia: A structured summary of a study protocol for a randomised controlled trial. Trials 2021; 22:270.

DOI

Cherlin S, Lewis MJ, Plant D, Nair N, Goldmann K, Tzanis E, Barnes MR, McKeigue P, Barrett JH, Pitzalis C, Barton A, MATURA Consortium, Cordell HJ (2020). Investigation of genetically regulated gene expression and response to treatment in rheumatoid arthritis highlights an association between IL18RAP expression and treatment response. Ann Rheum Dis 2021; 79:1446-52.

DOI

Cherlin S, Wason JMS (2020). Developing and testing high-efficacy patient subgroups within a clinical trial using risk scores. Stat Med 2020; 39:3285-98.

DOI

Castellucci LC, Almeida L, Cherlin C, Fakiola M, Carvalho E, Figueiredo AB, Cavalcanti CM, Alves NS, Dutra WO, Gollob KJ, Cordell HJ, Blackwell JM (2020). A genome-wide association study highlights a regulatory role for IFNG-AS1 contributing to cutaneous leishmaniasis in Brazil. bioRxiv 2020; doi:10.1101/2020.01.13.903989.

DOI

Heaps S, Nye T, Boys R, Williams T, Cherlin S, Embley M (2019). Generalizing rate heterogeneity across sites in statistical phylogenetics. Stat Model 2019.

DOI

Cherlin S, Plant D, Taylor JC, Colombo M, Spiliopoulou A, Tzanis E, Morgan AW, Barnes MR, McKeigue P, Barrett JH, Pitzalis C, Barton A, MATURA Consortium, Cordell HJ (2018). Prediction of treatment response in rheumatoid arthritis patients using genome-wide SNP data. Genetic Epidemiology 2018; 42:754-71.

DOI

Cherlin S, Wang MH, Bickeboller H, Cantor RM (2018). Detecting responses to treatment with fenofibrate in pedigrees. BMC Genet 2018; 19:64.

DOI

Cherlin S, Howey RAJ, Cordell HJ (2018). Using penalized regression to predict phenotype from SNP data. BMC Proc 2018; 12:38.

DOI

Cherlin S, Heaps S, Nye T, Boys R, Williams T, Embley M (2017). The effect of nonreversibility on inferring rooted phylogenies. Mol Biol Evol 2018; 35:984-1002.

DOI

Williams TA, Heaps SE, Cherlin S, Nye TMW, Boys RJ, Embley TM (2015). New substitution models for rooting phylogenetic trees. Philos T Roy Soc B 2015; 370:20140336.

DOI